Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / NeuroEM Therapeutics, Inc.

NeuroEM Therapeutics, Inc.

Stage unknownTampa, FLOther Health Care
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Apr 9, 2025
    Form D equity offering · $1.9M (form d sold) · 23 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “NeuroEM Therapeutics, Inc. filed Form D: $1,946,539 sold of $6,480,840, Other Health Care”
  2. May 31, 2024
    Form D equity offering · $360,000 (form d sold) · 12 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “NeuroEM Therapeutics, Inc. filed Form D: $360,000 sold of $500,000, Other Health Care”
Investors on record
0 edges
No named investor yet.
People
1 officers, 2 directors
Timeline
2
  1. Apr 23, 2025
    NeuroEM Therapeutics, Inc. filed Form D: $1,946,539 sold of $6,480,840, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jun 17, 2024
    NeuroEM Therapeutics, Inc. filed Form D: $360,000 sold of $500,000, Other Health Care
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company